Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 1691 to 1700 of 2575 total matches.

Imiquimod for Genital Warts

   
The Medical Letter on Drugs and Therapeutics • Dec 19, 1997  (Issue 1016)
was detectable in serum and about 1% was excreted in urine and feces. CLINICAL TRIALS — No clinical trials ...
Imiquimod (i mi kwi' mod) 5% cream (Aldara - 3M Pharmaceuticals) has been approved by the FDA for treatment of external genital and perianal warts (condyloma acuminata). The drug requires a prescription but is applied by the patient. It is the second patient-applied treatment to become available for external genital warts; the first was podofilox (Condylox - Medical Letter, 33:117, 1991).
Med Lett Drugs Ther. 1997 Dec 19;39(1016):118-9 |  Show IntroductionHide Introduction

Are SSRIs Safe for Children?

   
The Medical Letter on Drugs and Therapeutics • Jul 07, 2003  (Issue 1160)
), among a total of 1,134 childen aged 7-18 years, the effectiveness of paroxetine could ...
A "Dear Colleague" letter from the UK's Committee on Safety of Medicines advised physicians, on the basis of unpublished data, not to use paroxetine (Paxil in the US; Seroxat in the UK) to treat children and adolescents with depression because of possible increased risk of suicidal behavior. This review describes the efficacy and safety of SSRIs in children.
Med Lett Drugs Ther. 2003 Jul 7;45(1160):53-4 |  Show IntroductionHide Introduction

In Brief: Genetic Test for Carbamazepine-Induced Stevens-Johnson Syndrome

   
The Medical Letter on Drugs and Therapeutics • Apr 21, 2008  (Issue 1284)
but also trigeminal neuralgia and manic episodes in patients with bipolar disorder, 1 is a known cause ...
Genetic Test for Carbamazepine-Induced Stevens-Johnson Syndrome Carbamazepine (Tegretol, Carbatrol, Equetro, and others), which is now used to treat not only epilepsy but also trigeminal neuralgia and manic episodes in patients with bipolar disorder,1 is a known cause of Stevens-Johnson syndrome (SJS). The incidence of carbamazepine-induced SJS in countries with mainly white populations is 1 to 6 per 10,000 new users of the drug, but Asian patients have a 10-fold higher incidence of this reaction. An association has been found between the human leukocyte antigen (HLA)-B*1502 allele and...
Med Lett Drugs Ther. 2008 Apr 21;50(1284):29 |  Show IntroductionHide Introduction

In Brief: Measles Outbreak

   
The Medical Letter on Drugs and Therapeutics • Jun 02, 2008  (Issue 1287)
Advisory, May 1, 2008). To date, 63 of the 64 infected patients were unvaccinated, and 54 of the cases ...
The US Centers for Disease Control and Prevention (CDC) has reported that measles outbreaks have occurred in New York City, California and Arizona in 2008, and additional cases have been confirmed in Michigan, Wisconsin, Hawaii, New York State, Pennsylvania, Illinois and Virginia (CDC Health Advisory, May 1, 2008). To date, 63 of the 64 infected patients were unvaccinated, and 54 of the cases were associated with importation of the disease. Both measles infection and vaccination (2 doses at least 28 days apart, with the first dose no earlier than 12 months of age) generally provide lifelong...
Med Lett Drugs Ther. 2008 Jun 2;50(1287):41 |  Show IntroductionHide Introduction

Corrections

   
The Medical Letter on Drugs and Therapeutics • Aug 24, 2009  (Issue 1319)
: Benzyl Alcohol Lotion for Head Lice (Med Lett Drugs Ther 2009; 51:57) In Table 1, the price ...
Benzyl Alcohol Lotion for Head Lice (Med Lett Drugs Ther 2009; 51:57) In Table 1, the price for lindane 1% shampoo should be $136.86 (not $3.00). When a Statin Fails (Med Lett Drugs Ther 2009; 51:58) The first sentence should read as follows: "The National Cholesterol Program recommends that LDL-C be lowered to less than 100 mg/dL (2.6 mmol/L) for patients at high risk...." Tapentadol (Nucynta) - A New Analgesic (Med Lett Drugs Ther 2009; 51:61) In table 1, the half-life for tapentadol should be 4 hours (not...
Med Lett Drugs Ther. 2009 Aug 24;51(1319):68 |  Show IntroductionHide Introduction

Denosumab (Prolia) for Postmenopausal Osteoporosis

   
The Medical Letter on Drugs and Therapeutics • Oct 18, 2010  (Issue 1349)
fracture from 1.2% to 0.7%, and nonvertebral fracture from 8.0% to 6.5%, all statistically significant ...
The FDA has approved use of denosumab (Prolia – Amgen) for treatment of osteoporosis in postmenopausal women at high risk for fracture.
Med Lett Drugs Ther. 2010 Oct 18;52(1349):81-2 |  Show IntroductionHide Introduction

Extended-Release Trazodone (Oleptro) for Depression

   
The Medical Letter on Drugs and Therapeutics • Nov 15, 2010  (Issue 1351)
years, but is used mostly in low doses for its sedating effects.1 MECHANISM OF ACTION — Trazodone ...
The FDA has approved the marketing of an extended-release formulation of trazodone (Oleptro – Angelini Labopharm) for treatment of major depressive disorder in adults. Immediate-release trazodone has been available for treatment of depression for many years, but is used mostly in low doses for its sedating effects.
Med Lett Drugs Ther. 2010 Nov 15;52(1351):91-2 |  Show IntroductionHide Introduction

Miconazole (Oravig) for Oropharyngeal Candidiasis

   
The Medical Letter on Drugs and Therapeutics • Nov 29, 2010  (Issue 1352)
infections and vulvovaginal candidiasis.1 OROPHARYNGEAL CANDIDIASIS — Clotrimazole troches or nystatin ...
The FDA has approved a buccal tablet formulation of miconazole (Oravig – Strativa) for local treatment of oropharyngeal candidiasis in adults. Miconazole has been available for many years in topical formulations for treatment of superficial fungal infections and vulvovaginal candidiasis.
Med Lett Drugs Ther. 2010 Nov 29;52(1352):95-6 |  Show IntroductionHide Introduction

Ruxolitinib (Jakafi) for Myelofibrosis

   
The Medical Letter on Drugs and Therapeutics • Apr 02, 2012  (Issue 1387)
occur in about 50% of patients with myelofibrosis.1 Inhibition of JAK1 and JAK2 results ...
The FDA has approved ruxolitinib (Jakafi – Incyte), a janus-associated kinase (JAK) inhibitor, for treatment of myelofibrosis. Jakafi is the first JAK inhibitor to be approved for any indication and the only drug approved for treatment of myelofibrosis.
Med Lett Drugs Ther. 2012 Apr 2;54(1387):27-8 |  Show IntroductionHide Introduction

Liptruzet: A Combination of Ezetimibe and Atorvastatin

   
The Medical Letter on Drugs and Therapeutics • Jun 24, 2013  (Issue 1419)
with simvastatin (Vytorin).1 CLINICAL STUDIES — FDA approval of Liptruzet was based on randomized, double-blind ...
The FDA has approved a fixed-dose combination of the cholesterol absorption inhibitor ezetimibe and the HMG-CoA reductase inhibitor (statin) atorvastatin as Liptruzet (Merck) for treatment of hyperlipidemia. Ezetimibe is also available in a fixed-dose combination with simvastatin (Vytorin).
Med Lett Drugs Ther. 2013 Jun 24;55(1419):49-50 |  Show IntroductionHide Introduction